Daclizumab as escape therapy for late acute kidney rejection in the presence of FK506 nephrotoxicity.

Abstract

Semantic Scholar extracted view of "Daclizumab as escape therapy for late acute kidney rejection in the presence of FK506 nephrotoxicity." by José Oberholzer et al.

Topics

    0 Figures and Tables

      Download Full PDF Version (Non-Commercial Use)